ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
NCT06194799
·
clinicaltrials.gov ↗
PHASE3
Phase
ENROLLING_BY_INVITATION
Status
752
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease Psychosis
Interventions
DRUG:
ACP-204
Sponsor
ACADIA Pharmaceuticals Inc.